Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 3/20 | 0.68 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.68 |
| ▸ | LGALS4 | P56470 | 3/20 | 0.68 |
| ▸ | GJB2 | P29033 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.52 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.49 |
| ▸ | GBA1 | P04062 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15450956 | 0.94 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL22431206 | 0.94 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL22067763 | 0.94 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL23393554 | 0.94 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL18685567 | 0.94 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL23183598 | 0.94 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL22067762 | 0.94 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL25005884 | 0.94 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL21068067 | 0.94 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 | |
| SCHEMBL12908202 | 0.94 | LGALS8 (0.77) | LGALS8LGALS3LGALS4GJB2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8822191-B2 | Methods of refolding mammalian glycosyltransferases | NOVO NORDISK A/S (DK) | 2014-09-02 | — | — | US | disclosed |
| EP-2484759-B1 | Methods of refolding mammalian glycosyltransferases | RATIOPHARM GMBH (DE) | 2014-06-25 | — | — | EP | disclosed |
| EP-2484759-A2 | Methods of refolding mammalian glycosyltransferases | BioGeneriX AG (DE) | 2012-08-08 | — | — | EP | disclosed |
| EP-1718739-B1 | METHODS OF REFOLDING MAMMALIAN GLYCOSYLTRANSFERASES | NOVO NORDISK AS (DK) | 2011-07-13 | — | — | EP | disclosed |
| EP-1718739-A4 | METHODS OF REFOLDING MAMMALIAN GLYCOSYLTRANSFERASES | NOVO NORDISK AS (DK) | 2009-08-05 | — | — | EP | disclosed |
| US-20070269879-A1 | Methods of Refolding Mammalian Glycosyltranferases | NEOSE TECHNOLOGIES, INC. (US) | 2007-11-22 | — | — | US | disclosed |
| EP-1718739-A2 | METHODS OF REFOLDING MAMMALIAN GLYCOSYLTRANSFERASES | Neose Technologies, Inc. (US) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005089102-A9 | METHODS OF REFOLDING MAMMALIAN GLYCOSYLTRANSFERASES | NEOSE TECHNOLOGIES INC (US) | 2006-03-16 | — | — | WO | disclosed |
| WO-2005089102-A2 | METHODS OF REFOLDING MAMMALIAN GLYCOSYLTRANSFERASES | NEOSE TECHNOLOGIES, INC. (US) | 2005-09-29 | — | — | WO | disclosed |